Physician profile
Kun Li
NPI 1467655852
$5,120.92
in general payments reported to CMS, 2019-2025
37 companies · $1,914 in 2025
The $1,914 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $110 · 2021: $14.26 · 2023: $855 · 2024: $1,653 · 2025: $1,914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,422.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $822.64 | 2019-2025 | |
| Novo Nordisk INC | $776.57 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $573.53 | 2023-2025 | Rexulti |
| Abbvie INC. | $455.62 | 2023-2025 | |
| Lilly USA, LLC | $431.48 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $403.35 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Dexcom, INC. | $319.30 | 2024-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $153.16 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Ironshore Pharmaceuticals INC. | $144.29 | 2019-2024 | Jornay Pm |
| Exact Sciences Corporation | $122.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $98.14 | 2019-2024 | Dificid, Gardasil, Capvaxive |
| Amgen INC. | $73.03 | 2019-2025 | Repatha, Otezla |
| Vanda Pharmaceuticals INC. | $69.40 | 2025 | Fanapt |
| Boston Scientific Corporation | $60.76 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Mylan Specialty L.P. | $53.09 | 2024 | Yupelri |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kun Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.